Zobrazeno 1 - 2
of 2
pro vyhledávání: '"RCh Levy-Abitbol"'
Autor:
A. Padilla-Galo, RCh Levy-Abitbol, C. Olveira, B. Valencia Azcona, M. Pérez Morales, F. Rivas-Ruiz, B. Tortajada-Goitia, I. Moya-Carmona, A. Levy-Naon
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Benralizumab is a monoclonal antibody that binds to the human interleukin-5 (IL-5) receptor (IL-5R), thereby preventing IL-5 from binding to its receptor and inhibiting differentiation and maturation of eosinophils in the bone mar
Externí odkaz:
https://doaj.org/article/927ef4563ea249bf88ce7e5e4ab07d4e
Autor:
Francisco Rivas-Ruiz, Casilda Olveira, Alicia Padilla-Galo, I. Moya-Carmona, B. Tortajada-Goitia, M. Pérez Morales, RCh Levy-Abitbol, A. Levy-Naon, B. Valencia Azcona
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-12 (2020)
BackgroundBenralizumab is a monoclonal antibody that binds to the human interleukin-5 (IL-5) receptor (IL-5R), thereby preventing IL-5 from binding to its receptor and inhibiting differentiation and maturation of eosinophils in the bone marrow. Becau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74b440e70d86f9c3babc5660932cb91
https://doi.org/10.1186/s12890-020-01220-9
https://doi.org/10.1186/s12890-020-01220-9